Wells Fargo & Company »

Atara Biotherapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.5k 251 18.09
2025-09-30 $3.6k 251 14.33
2025-06-30 $7.3k 951 7.72
2025-03-31 $5.6k 951 5.94
2024-12-31 $13k 951 13.31
2024-09-30 $10k 1.3k 8.13
2024-06-30 $2.7k 315 8.50